A retrospective cohort study: pre-operative oral enteral nutritional optimisation for Crohn's disease in a UK tertiary IBD centre.

Publication Year: 2022

DOI:
10.1111/apt.17055

PMCID:
PMC9544188

PMID:
35723622

Journal Information

Full Title: Aliment Pharmacol Ther

Abbreviation: Aliment Pharmacol Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data s1 click here for additional data file."

Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST SM has received speaker fees from FalkPharma and an educational grant from Pfizer. KP has received honoraria for educational meetings and speaker fees from Abbvie, Janssen, Takeda, DrFalk, PredictImmune and Ferring. KP has received Advisory Board fees from Abbvie, Galapagos and Janssen. RPL has received educational grants from Ferring, Pfizer and Vifor Pharma. PMI: AbbVie, Celgene, Falk Pharma, Ferring MSD, Janssen, Pfizer, Takeda, Tillotts, Sandoz, Shire, Warner Chilcott ‐ Speaking/education, intermittent (last 3 years). SH has received lecture fees from Pfizer, Janssen and Takeda. DOH, AC, PP, CA, NG, SZ, SR, JM, MAS, SHA, KA, AD, AW, JDS, ML none declared."

Evidence found in paper:

"Funding information No funding was required for this project"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025